Carbromal

This classification denotes a sedative and hypnotic with the molecular formula C7H13BrN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0Y299JY9V3, chemically known as urea, (2-bromo-ethylbutyryl)- but generally known as carbromal, which bears US NIH Compound Identifier 6488. European Medicines Agency schedules Carbromal in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06617MIG. The term CARBROMAL is an International Non-Proprietary Name. World Health Organization schedules carbromal in its Anatomical Therapeutic Chemical (ATC) Classification. CARBROMAL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule carbromal under HS 29241900 and SITC 51471. As of Q4 2014, CARBROMAL remains the US FDA Preferred Term for this commodity. Carbromal bears US NLM identifiers UMLS ID C0007077 and NCI Concept Code C76936. SMILES: BRC(CC)(CC)C(=O)NC(=O)N.